Tag: Clinical trial

The median cost of bringing a new drug to market can be around $985 million, with an average cost of $1.3 billion [1.4.3]. The lengthy and expensive process that answers the question, **what is it called when a drug is being tested,** is known as a **clinical trial** [1.2.2].

Three deaths were assessed as related to donanemab treatment due to amyloid-related imaging abnormalities (ARIA) during the TRAILBLAZER-ALZ 2 trial, prompting a closer examination of the drug's safety profile. The question of 'How many people died in the donanemab trial?' has become central to discussions surrounding this new Alzheimer's medication, balancing its efficacy with significant safety concerns.

While 'Renne' is not a standard pharmaceutical term, the name is phonetically similar to several substances with distinct pharmacological roles, most commonly the antacid **Rennie**. A proper understanding requires differentiating between the over-the-counter medication Rennie, the enzyme Renin, the clinical trial ReNeu, and the discontinued diuretic Renese.